|
WO2016149628A1
|
|
Tgr5 agonists
|
|
US2015011539A1
|
|
Tyrosine kinase inhibitors
|
|
US2015038536A1
|
|
Tyrosine kinase inhibitors
|
|
US2014228350A1
|
|
Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
|
|
AU2013201173A1
|
|
Heterocyclic compounds as lyrosine kinase modulators
|
|
AU2009226153A1
|
|
Novel tyrosine kinase inhibitors
|
|
AU2007284542A1
|
|
Tricyclic compounds and its use as tyrosine kinase modulators
|
|
EP2298770A1
|
|
Heterocyclic compounds as TrkA modulators
|
|
AU2495499A
|
|
Supports for solid state chemical reactions and method of use thereof
|
